Related references
Note: Only part of the references are listed.Association of apolipoprotein E genotypes with lipid levels and coronary risk
Anna M. Bennet et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
AAV vector integration sites in mouse hepatocellular carcinoma
Anthony Donsante et al.
SCIENCE (2007)
Complete prevention of atherosclerosis in ApoE-deficient mice by hepatic human ApoE gene transfer with adeno-associated virus serotypes 7 and 8
Ken Kitajima et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver
AC Nathwani et al.
BLOOD (2006)
LDL receptor deficiency or apoE mutations prevent remnant clearance and induce hypertriglyceridemia in mice
KE Kypreos et al.
JOURNAL OF LIPID RESEARCH (2006)
Adeno-associated virus serotypes: Vector toolkit for human gene therapy
Zhijian Wu et al.
MOLECULAR THERAPY (2006)
Adeno-associated virus vector-mediated systemic delivery of IFN-β combined with low-dose cyclophosphamide affects tumor regression in murine neuroblastoma models
CJ Streck et al.
CLINICAL CANCER RESEARCH (2005)
Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo
E Riu et al.
HUMAN GENE THERAPY (2005)
Gene transfer into skeletal muscle using novel AAV serotypes
JP Louboutin et al.
JOURNAL OF GENE MEDICINE (2005)
Towards safe, non-viral therapeutic gene expression in humans
DJ Glover et al.
NATURE REVIEWS GENETICS (2005)
Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver
H Nakai et al.
JOURNAL OF VIROLOGY (2005)
Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels
RL Raffai et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Apolipoprotein E delivery by peritoneal implantation of encapsulated recombinant cells improves the hyperlipidaemic profile in apoE-deficient mice
AD Tagalakis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2005)
Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors
CE Thomas et al.
JOURNAL OF VIROLOGY (2004)
Therapeutic levels of factor IX expression using a muscle-specific promoter and adeno-associated virus serotype 1 vector
YL Liu et al.
HUMAN GENE THERAPY (2004)
Atherosclerosis in the apolipoprotein E-deficient mouse - A decade of progress
KS Meir et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Genetic fate of recombinant adeno-associated virus vector genomes in muscle
BC Schnepp et al.
JOURNAL OF VIROLOGY (2003)
High-efficiency plasmid gene transfer into dystrophic muscle
H Gollins et al.
GENE THERAPY (2003)
Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo
Z Wang et al.
GENE THERAPY (2003)
Non-viral gene delivery in skeletal muscle: a protein factory
QL Lu et al.
GENE THERAPY (2003)
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
GP Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Hyaluronidase increases electrogene transfer efficiency in skeletal muscle
C Mennuni et al.
HUMAN GENE THERAPY (2002)
Inhibition of atherosclerosis in apolipoprotein-E-deficient mice following muscle transduction with adeno-associated virus vectors encoding human apolipoprotein-E
JD Harris et al.
GENE THERAPY (2002)
Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1(-), E3(-), polymerase(-)] adenovirus vector expressing human apoE
JD Harris et al.
HUMAN MOLECULAR GENETICS (2002)
Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells
AK Stannard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase - increased expression with reduced muscle damage
JM McMahon et al.
GENE THERAPY (2001)
CMV-β-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1α promoter and results in therapeutic levels of human factor X in mice
LF Xu et al.
HUMAN GENE THERAPY (2001)
Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by intramuscular injection of plasmid DNA
M Rinaldi et al.
GENE THERAPY (2000)
Intramuscular injection of a plasmid vector expressing human apolipoprotein E limits progression of xanthoma and aortic atheroma in apoE-deficient mice
T Athanasopulos et al.
HUMAN MOLECULAR GENETICS (2000)
Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice
FE Thorngate et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors
MA Hauser et al.
MOLECULAR THERAPY (2000)
Share Paper
